Orexins and primary headaches: an overview of the neurobiology and clinical impact

References

• Kopel D, Gottschalk C. The epidemiology of primary headache disorders. Semin Neurol. 2022;42(4):449–458. doi: 10.1055/a-1942-6823
   PubMedGoogle Scholar
• Onofri A, Pensato U, Rosignoli C, et al. Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis. J Headache Pain. 2023;24(1):8. doi: 10.1186/s10194-023-01541-0
   PubMed Web of Science ®Google Scholar
• Lipton RB, Liberman JN, Kolodner KB, et al. Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia. 2003;23(6):441–450. doi: 10.1046/j.1468-2982.2003.00546.x
   PubMed Web of Science ®Google Scholar
• Abu Bakar N, Tanprawate S, Lambru G, et al. Quality of life in primary headache disorders: a review. Cephalalgia. 2016;36(1):67–91. doi: 10.1177/0333102415580099
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. doi: 10.1177/0333102417738202
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007;13(1):39–44. doi: 10.1016/j.molmed.2006.11.005
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Primary headache disorders: five new things. Neurol Clin Pract. 2019;9(3):233–240. doi: 10.1212/CPJ.0000000000000654
   PubMedGoogle Scholar
• Buture A, Boland JW, Dikomitis L, et al. Update on the pathophysiology of cluster headache: imaging and neuropeptide studies. J Pain Res. 2019;12:269–281. doi: 10.2147/JPR.S175312
   PubMed Web of Science ®Google Scholar
• Khan J, Asoom LIA, Sunni AA, et al. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother. 2021;139:111557. doi: 10.1016/j.biopha.2021.111557
   PubMed Web of Science ®Google Scholar
• Brandt RB, Doesborg PGG, Haan J, et al. Pharmacotherapy for cluster headache. CNS Drugs. 2020;34(2):171–184. doi: 10.1007/s40263-019-00696-2
   PubMed Web of Science ®Google Scholar
• Moreno-Ajona D, Villar-Martínez MD, Goadsby PJ Emerging targets for migraine treatment. Neurol India. 2021;69:98. 7 10.4103/0028-3886.315989
   Google Scholar
• Strother LC, Srikiatkhachorn A, Supronsinchai W. Targeted orexin and hypothalamic neuropeptides for migraine. Neurotherapeutics. 2018;15(2):377–390. doi: 10.1007/s13311-017-0602-3
   PubMed Web of Science ®Google Scholar
• Saper CB, Lowell BB. The hypothalamus. Curr Biol. 2014;24(23):R1111–R1116. doi: 10.1016/j.cub.2014.10.023
   PubMed Web of Science ®Google Scholar
• Montagna P. Hypothalamus, sleep and headaches. Neurol Sci. 2006;27(S2):s138–s143. doi: 10.1007/s10072-006-0589-8
   PubMedGoogle Scholar
• Schulte LH, Allers A, May A. Hypothalamus as a mediator of chronic migraine: evidence from high-resolution fMRI. Neurology. 2017;88(21):2011–2016. doi: 10.1212/WNL.0000000000003963
   PubMed Web of Science ®Google Scholar
• Denuelle M, Fabre N, Payoux P, et al. Hypothalamic activation in spontaneous migraine attacks. Headache. 2007;47(10):1418–1426. doi: 10.1111/j.1526-4610.2007.00776.x
   PubMed Web of Science ®Google Scholar
• Maniyar FH, Sprenger T, Monteith T, et al. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014;137(1):232–241. doi: 10.1093/brain/awt320
   PubMedGoogle Scholar
• Sprenger T, Boecker H, Tolle TR, et al. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology. 2004;62(3):516–517. doi: 10.1212/WNL.62.3.516
   PubMed Web of Science ®Google Scholar
• Moulton EA, Becerra L, Johnson A, et al. Altered hypothalamic functional connectivity with autonomic circuits and the locus coeruleus in Migraine. PloS One. 2014;9(4):e95508. doi: 10.1371/journal.pone.0095508
   PubMed Web of Science ®Google Scholar
• Lerebours F, Boulanouar K, Barège M, et al. Functional connectivity of hypothalamus in chronic migraine with medication overuse. Cephalalgia. 2019;39(7):892–899. doi: 10.1177/0333102419833087
   PubMed Web of Science ®Google Scholar
• Meylakh N, Marciszewski KK, Di Pietro F, et al. Altered regional cerebral blood flow and hypothalamic connectivity immediately prior to a migraine headache. Cephalalgia. 2020;40(5):448–460. doi: 10.1177/0333102420911623
   PubMed Web of Science ®Google Scholar
• Messina R, Rocca MA, Valsasina P, et al. 2022 Clinical correlates of hypothalamic functional changes in migraine patients [internet]. [cited 2023 May 17]. Available from: https://journals.sagepub.com/doi/full/10.1177/03331024211046618.
   Google Scholar
• Coppola G, Di Renzo A, Petolicchio B, et al. Increased neural connectivity between the hypothalamus and cortical resting-state functional networks in chronic migraine. J Neurol. 2020;267(1):185–191. doi: 10.1007/s00415-019-09571-y
   PubMed Web of Science ®Google Scholar
• Benkli B, Kim SY, Koike N, et al. Circadian features of cluster headache and migraine: a systematic review, meta-analysis, and genetic analysis. Neurology. 2023;100(22):e2224–e2236. doi: 10.1212/WNL.0000000000207240
   PubMed Web of Science ®Google Scholar
• Stanyer EC, Brookes J, Pang JR, et al. Investigating the relationship between sleep and migraine in a global sample: a Bayesian cross-sectional approach. J Headache Pain. 2023;24(1):123. doi: 10.1186/s10194-023-01638-6
   PubMed Web of Science ®Google Scholar
• Engstrøm M, Hagen K, Bjørk M, et al. Sleep-related and non-sleep-related migraine: interictal sleep quality, arousals and pain thresholds. J Headache Pain. 2013;14(1):68. doi: 10.1186/1129-2377-14-68
   PubMedGoogle Scholar
• Dexter JD. The relationship between stage III + IV + REM sleep and arousals with Migraine. Headache. 1979;19(7):364–369. doi: 10.1111/j.1526-4610.1979.hed1907364.x
   PubMed Web of Science ®Google Scholar
• Dexter JD, Riley TL. Studies in Nocturnal migraine. Headache. 1975;15(1):51–62. doi: 10.1111/j.1526-4610.1975.hed1501051.x
   PubMed Web of Science ®Google Scholar
• Barloese M, Lund N, Petersen A, et al. Sleep and chronobiology in cluster headache. Cephalalgia. 2015;35(11):969–978. doi: 10.1177/0333102414564892
   PubMed Web of Science ®Google Scholar
• Stanyer EC, Creeney H, Nesbitt AD, et al. Subjective sleep quality and sleep architecture in patients with migraine: a meta-analysis. Neurology [Internet]. 2021 [cited 2021 Sep 24;97 16. doi: 10.1212/WNL.0000000000012701
   PubMed Web of Science ®Google Scholar
• Karsan N, Goadsby PJ. Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol. 2018;14(12):699–710. doi: 10.1038/s41582-018-0098-4
   PubMed Web of Science ®Google Scholar
• May A, Burstein R. Hypothalamic regulation of headache and migraine. Cephalalgia. 2019;39(13):1710–1719. doi: 10.1177/0333102419867280
   PubMed Web of Science ®Google Scholar
• van den Pol AN, Tsujimoto KL. Neurotransmitters of the hypothalamic suprachiasmatic nucleus: immunocytochemical analysis of 25 neuronal antigens. Neuroscience. 1985;15:1049–1086. doi: 10.1016/0306-4522(85)90254-4
   PubMed Web of Science ®Google Scholar
• Holland P, Goadsby PJ. The hypothalamic orexinergic system: pain and primary headaches. Headache. 2007;47(6):951–962. doi: 10.1111/j.1526-4610.2007.00842.x
   PubMed Web of Science ®Google Scholar
• Holland PR The orexins and their involvement in the modulation of trigeminovascular nociceptive transmission [Internet] [ PhD Thesis]. UCL (University College London); 2006 [cited 2024 Feb 20]. Available from: https://discovery.ucl.ac.uk/id/eprint/1445638/.
   Google Scholar
• Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573–585. doi: 10.1016/S0092-8674(00)80949-6
   PubMed Web of Science ®Google Scholar
• Lang M, Söll RM, Dürrenberger F, et al. Structure−activity studies of orexin a and orexin B at the human orexin 1 and orexin 2 receptors led to orexin 2 receptor selective and orexin 1 receptor preferring ligands. J Med Chem. 2004;47(5):1153–1160. doi: 10.1021/jm030982t
   PubMed Web of Science ®Google Scholar
• de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Procs Nati Aca Scie. 1998;95:322–327.
   Google Scholar
• Marcus JN, Aschkenasi CJ, Lee CE, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 2001;435(1):6–25. doi: 10.1002/cne.1190
   PubMed Web of Science ®Google Scholar
• Marcus JN, Elmquist JK. Orexin projections and localization of orexin receptors. In: Nishino S Sakurai T editors. The Orexin/Hypocretin System: physiology and pathophysiology [internet]. Totowa (NJ): Humana Press; 2005 [cited 2023 May 16]p. 21–43. Available from. doi: 10.1385/1-59259-950-8:21
   Google Scholar
• Thorpe AJ, Kotz CM. Orexin a in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res. 2005;1050(1–2):156–162. doi: 10.1016/j.brainres.2005.05.045
   PubMed Web of Science ®Google Scholar
• Hervieu GJ, Cluderay JE, Harrison DC, et al. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience. 2001;103(3):777–797. doi: 10.1016/S0306-4522(01)00033-1
   PubMed Web of Science ®Google Scholar
• Kirouac GJ, Parsons MP, Li S. Orexin (hypocretin) innervation of the paraventricular nucleus of the thalamus. Brain Res. 2005;1059(2):179–188. doi: 10.1016/j.brainres.2005.08.035
   PubMed Web of Science ®Google Scholar
• Stoyanova II, Lazarov NE. Localization of orexin-A-immunoreactive fibers in the mesencephalic trigeminal nucleus of the rat. Brain Res. 2005;1054:82–87. doi: 10.1016/j.brainres.2005.06.066
   PubMed Web of Science ®Google Scholar
• Peyron C, Tighe DK, van den AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18:9996–10015. 23. doi: 10.1523/JNEUROSCI.18-23-09996.1998
   PubMed Web of Science ®Google Scholar
• Rosin DL, Weston MC, Sevigny CP, et al. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol. 2003;465(4):593–603. doi: 10.1002/cne.10860
   PubMed Web of Science ®Google Scholar
• Chou TC, Lee CE, Lu J, et al. Orexin (hypocretin) neurons contain dynorphin. J Neurosci. 2001;21(19):RC168–RC168. doi: 10.1523/JNEUROSCI.21-19-j0003.2001
   PubMed Web of Science ®Google Scholar
• Trivedi P, Yu H, MacNeil DJ, et al. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 1998;438(1–2):71–75. doi: 10.1016/S0014-5793(98)01266-6
   PubMed Web of Science ®Google Scholar
• Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007;8(3):171–181. doi: 10.1038/nrn2092
   PubMed Web of Science ®Google Scholar
• Ferguson AV, Samson WK. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol. 2003;24(3):141–150. doi: 10.1016/S0091-3022(03)00028-1
   PubMed Web of Science ®Google Scholar
• Aston-Jones G, Smith RJ, Moorman DE, et al. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology. 2009;56:112–121. doi: 10.1016/j.neuropharm.2008.06.060
   PubMed Web of Science ®Google Scholar
• Sargin D. The role of the orexin system in stress response. Neuropharmacology. 2019;154:68–78. doi: 10.1016/j.neuropharm.2018.09.034
   PubMed Web of Science ®Google Scholar
• Sakurai T. Orexins and orexin receptors: implication in feeding behavior. Regul Pept. 1999;85(1):25–30. doi: 10.1016/S0167-0115(99)00076-2
   PubMedGoogle Scholar
• Inutsuka A, Yamashita A, Chowdhury S, et al. The integrative role of orexin/hypocretin neurons in nociceptive perception and analgesic regulation. Sci Rep. 2016;6(1):1–15. doi: 10.1038/srep29480
   PubMedGoogle Scholar
• Sureda Gibert P Investigating the migraine premonitory phase: neural networks regulating migraine initiation [Internet] [PhD Thesis]KCL (King’s College London); 2022 [cited 2024 Feb 20] Available from: https://kclpure.kcl.ac.uk/ws/portalfiles/portal/249095126/2022_Sureda_Gibert_1309897_ethesis.pdf.
   Google Scholar
• Gerashchenko D, Kohls MD, Greco M, et al. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci. 2001;21(18):7273–7283. doi: 10.1523/JNEUROSCI.21-18-07273.2001
   PubMed Web of Science ®Google Scholar
• Levitt DR, Teitelbaum P Somnolence, akinesia, and sensory activation of motivated behavior in the lateral hypothalamic syndrome. Procs Nati Aca Scie. 1975;72:2819–2823.
   Google Scholar
• Alexandre C, Andermann ML, Scammell TE. Control of arousal by the orexin neurons. Curr Opin Neurobiol. 2013;23(5):752–759. doi: 10.1016/j.conb.2013.04.008
   PubMed Web of Science ®Google Scholar
• De Luca R, Nardone S, Grace KP, et al. Orexin neurons inhibit sleep to promote arousal. Nat Commun. 2022;13(1):4163. doi: 10.1038/s41467-022-31591-y
   PubMed Web of Science ®Google Scholar
• Matsuki T, Takasu M, Hirose Y, et al. GABAA receptor-mediated input change on orexin neurons following sleep deprivation in mice. Neuroscience. 2015;284:217–224. doi: 10.1016/j.neuroscience.2014.09.063
   PubMed Web of Science ®Google Scholar
• Hagan JJ, Leslie RA, Patel S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Procs Nati Aca Scie. 1999;96:10911–10916.
   Google Scholar
• Yamanaka A, Tabuchi S, Tsunematsu T, et al. Orexin directly excites orexin neurons through orexin 2 receptor. J Neurosci. 2010;30(38):12642–12652. doi: 10.1523/JNEUROSCI.2120-10.2010
   PubMed Web of Science ®Google Scholar
• Coleman PJ, Gotter AL, Herring WJ, et al. The discovery of suvorexant, the first orexin receptor drug for insomnia. Annu Rev Pharmacol Toxicol. 2017;57(1):509–533. doi: 10.1146/annurev-pharmtox-010716-104837
   PubMed Web of Science ®Google Scholar
• Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98(3):365–376. doi: 10.1016/S0092-8674(00)81965-0
   PubMed Web of Science ®Google Scholar
• Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3(1):1–19. doi: 10.1038/nrdp.2016.100
   Web of Science ®Google Scholar
• Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27(3):469–474. doi: 10.1016/S0896-6273(00)00058-1
   PubMed Web of Science ®Google Scholar
• Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6(9):991–997. doi: 10.1038/79690
   PubMed Web of Science ®Google Scholar
• Dahmen N, Kasten M, Wieczorek S, et al. Increased frequency of migraine in narcoleptic patients: a confirmatory study. Cephalalgia. 2003;23(1):14–19. doi: 10.1046/j.1468-2982.2003.00343.x
   PubMed Web of Science ®Google Scholar
• Yang C-P, Hsieh M-L, Chiang J-H, et al. Migraine and risk of narcolepsy in children: a nationwide longitudinal study. PloS One. 2017;12(12):e0189231. doi: 10.1371/journal.pone.0189231
   PubMed Web of Science ®Google Scholar
• Willie JT, Chemelli RM, Sinton CM, et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron. 2003;38(5):715–730. doi: 10.1016/S0896-6273(03)00330-1
   PubMed Web of Science ®Google Scholar
• Kantor S, Mochizuki T, Janisiewicz AM, et al. Orexin neurons are necessary for the circadian control of REM sleep. Sleep. 2009;32(9):1127–1134. doi: 10.1093/sleep/32.9.1127
   PubMed Web of Science ®Google Scholar
• Akyildiz UO, Tezer FI, Koc G, et al. The REM-sleep-related characteristics of narcolepsy: a nation-wide multicenter study in Turkey, the REMCON study. Sleep Med. 2022;94:17–25. doi: 10.1016/j.sleep.2022.03.025
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ren R, Yang L, et al. Polysomnographic nighttime features of narcolepsy: a systematic review and meta-analysis. Sleep Med Rev. 2021;58:101488. doi: 10.1016/j.smrv.2021.101488
   PubMed Web of Science ®Google Scholar
• Taheri S, Sunter D, Dakin C, et al. Diurnal variation in orexin a immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci lett. 2000;279(2):109–112. doi: 10.1016/S0304-3940(99)00955-6
   PubMed Web of Science ®Google Scholar
• Grady SP, Nishino S, Czeisler CA, et al. Diurnal variation in CSF orexin-A in healthy male subjects. Sleep. 2006;29(3):295–297. doi: 10.1093/sleep/29.3.295
   PubMed Web of Science ®Google Scholar
• Kiyashchenko LI, Mileykovskiy BY, Maidment N, et al. Release of hypocretin (orexin) during waking and sleep states. J Neurosci. 2002;22(13):5282–5286. doi: 10.1523/JNEUROSCI.22-13-05282.2002
   PubMed Web of Science ®Google Scholar
• Estabrooke IV, McCarthy MT, Ko E, et al. Fos expression in orexin neurons varies with behavioral state. J Neurosci. 2001;21:1656–1662. 5 10.1523/JNEUROSCI.21-05-01656.2001
   PubMed Web of Science ®Google Scholar
• Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27(5):394–402. doi: 10.1111/j.1468-2982.2007.01303.x
   PubMed Web of Science ®Google Scholar
• Pergolizzi JV, Magnusson P, LeQuang JA, et al. Exploring the connection between sleep and cluster headache: a narrative review. Pain Ther. 2020;9(2):359–371. doi: 10.1007/s40122-020-00172-6
   PubMed Web of Science ®Google Scholar
• Siemian JN, Borja CB, Sarsfield S, et al. Lateral hypothalamic fast-spiking parvalbumin neurons modulate nociception through connections in the periaqueductal gray area. Sci Rep. 2019;9(1):12026. doi: 10.1038/s41598-019-48537-y
   PubMedGoogle Scholar
• Bingham S, Davey PT, Babbs AJ, et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 2001;92(1):81–90. doi: 10.1016/S0304-3959(00)00470-X
   PubMed Web of Science ®Google Scholar
• Razavi BM, Hosseinzadeh H. A review of the role of orexin system in pain modulation. Biomed Pharmacother. 2017;90:187–193. doi: 10.1016/j.biopha.2017.03.053
   PubMed Web of Science ®Google Scholar
• Holland PR, Goadsby PJ. Cluster headache, hypothalamus, and orexin. Current Science Inc. 2009;13(2):147–154. doi: 10.1007/s11916-009-0025-x
   Google Scholar
• Lopez R, Young SL, Cox VC. Analgesia for formalin-induced pain by lateral hypothalamic stimulation. Brain Res. 1991;563(1–2):1–6. doi: 10.1016/0006-8993(91)91506-V
   PubMed Web of Science ®Google Scholar
• Aimone LD, Bauer CA, Gebhart GF. Brain-stem relays mediating stimulation-produced antinociception from the lateral hypothalamus in the rat. J Neurosci. 1988;8(7):2652–2663. doi: 10.1523/JNEUROSCI.08-07-02652.1988
   PubMed Web of Science ®Google Scholar
• Carstens E. Hypothalamic inhibition of rat dorsal horn neuronal responses to noxious skin heating. Pain. 1986;25(1):95–107. doi: 10.1016/0304-3959(86)90012-6
   PubMed Web of Science ®Google Scholar
• Millan MJ, Przewlocki R, Millan MH, et al. Evidence for a role of the ventro-medial posterior hypothalamus in nociceptive processes in the rat. Pharmacol Biochem Behav. 1983;18(6):901–907. doi: 10.1016/S0091-3057(83)80013-6
   PubMed Web of Science ®Google Scholar
• Behbehani MM, Park MR, Clement ME. Interactions between the lateral hypothalamus and the periaqueductal gray. J Neurosci. 1988;8(8):2780–2787. doi: 10.1523/JNEUROSCI.08-08-02780.1988
   PubMed Web of Science ®Google Scholar
• Kajiyama S, Kawamoto M, Shiraishi S, et al. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats. Brain Res. 2005;1044(1):76–86. doi: 10.1016/j.brainres.2005.03.007
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Saito O, Shono K, et al. Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model. Neurosci lett. 2003;347(3):183–186. doi: 10.1016/S0304-3940(03)00716-X
   PubMed Web of Science ®Google Scholar
• Heidari-Oranjaghi N, Azhdari-Zarmehri H, Erami E, et al. Antagonism of orexin-1 receptors attenuates swim- and restraint stress-induced antinociceptive behaviors in formalin test. Pharmacol Biochem Behav. 2012;103(2):299–307. doi: 10.1016/j.pbb.2012.08.007
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nozaki-Taguchi N, Chiba T. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br J Pharmacol. 2002;137(2):170–176. doi: 10.1038/sj.bjp.0704851
   PubMed Web of Science ®Google Scholar
• Mobarakeh JI, Takahashi K, Sakurada S, et al. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin a and B (hypocretin-1 and -2) in mice. Peptides. 2005;26(5):767–777. doi: 10.1016/j.peptides.2005.01.001
   PubMed Web of Science ®Google Scholar
• Bartsch T, Levy MJ, Knight YE, et al. Differential modulation of nociceptive dural input to [hypocretin] orexin a and B receptor activation in the posterior hypothalamic area. Pain. 2004;109(3):367–378. doi: 10.1016/j.pain.2004.02.005
   PubMed Web of Science ®Google Scholar
• Holland PR, Akerman S, Goadsby PJ. Orexin 1 Receptor Activation Attenuates Neurogenic Dural Vasodilation in an Animal Model of Trigeminovascular Nociception. J Pharmacol Exp Ther. 2005;315(3):1380–1385. doi: 10.1124/jpet.105.090951
   PubMed Web of Science ®Google Scholar
• Supronsinchai W, Hoffmann J, Akerman S, et al. Assessing the quality of health-related quality of life measures. Cephalalgia. 2013;33(4):223–225. SAGE PUBLICATIONS LTD 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND. doi: 10.1177/0333102412468681
   PubMed Web of Science ®Google Scholar
• Ashina M, Hansen JM, Á Dunga BO, et al. Human models of migraine — short-term pain for long-term gain. Nat Rev Neurol. 2017;13:713–724. 12 10.1038/nrneurol.2017.137
   PubMed Web of Science ®Google Scholar
• Askari-Zahabi K, Abbasnejad M, Kooshki R, et al. The role of basolateral amygdala orexin 1 receptors on the modulation of pain and psychosocial deficits in nitroglycerin-induced migraine model in adult male rats. Korean J Pain. 2022;35(1):22–32. doi: 10.3344/kjp.2022.35.1.22
   PubMed Web of Science ®Google Scholar
• Kooshki R, Abbasnejad M, Esmaeili-Mahani S, et al. Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats. Neuropharmacology. 2020;178:107981. doi: 10.1016/j.neuropharm.2020.107981
   PubMed Web of Science ®Google Scholar
• Pourrahimi AM, Abbasnejad M, Raoof M, et al. The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats. Peptides. 2021;146:170651. doi: 10.1016/j.peptides.2021.170651
   PubMed Web of Science ®Google Scholar
• Boss C, Roch C. Recent trends in orexin research—2010 to 2015. Bioorganic Med Chem Lett. 2015;25(15):2875–2887. doi: 10.1016/j.bmcl.2015.05.012
   PubMed Web of Science ®Google Scholar
• Sears RM, Fink AE, Wigestrand MB, et al. Orexin/Hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus. Procs Nati Aca Scie. 2013;110:20260–20265.
   Google Scholar
• Baskin SM, Lipchik GL, Smitherman TA. Mood and anxiety disorders in chronic headache. Headache. 2006;46(s3):S76–S87. doi: 10.1111/j.1526-4610.2006.00559.x
   PubMedGoogle Scholar
• Vila-Pueyo M, Strother LC, Kefel M, et al. Divergent influences of the locus coeruleus on migraine pathophysiology. Pain. 2019;160(2):385–394. doi: 10.1097/j.pain.0000000000001421
   PubMedGoogle Scholar
• May A, Bahra A, Buchel C, et al. PET and MRA findings in cluster headache and MRA in experimental pain. Neurology. 2000;55(9):1328–1335. doi: 10.1212/WNL.55.9.1328
   PubMed Web of Science ®Google Scholar
• May A, Bahra A, Büchel C, et al. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352(9124):275–278. doi: 10.1016/S0140-6736(98)02470-2
   PubMed Web of Science ®Google Scholar
• Cevoli S, Pizza F, Grimaldi D, et al. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. Cephalalgia. 2011;31(8):973–976. doi: 10.1177/0333102411403634
   PubMed Web of Science ®Google Scholar
• Barloese M. Reduced CSF hypocretin-1 levels are associated. Goo. [cited 2023 May 17]. Available from 10.1177/0333102414562971.
   Google Scholar
• Strittmatter M, Hamann GF, Grauer M, et al. Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache. Neuroreport. 1996;7(7):1229–1234. doi: 10.1097/00001756-199605170-00001
   PubMed Web of Science ®Google Scholar
• Rainero I, Gallone S, Valfrè W, et al. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology. 2004;63(7):1286–1288. doi: 10.1212/01.WNL.0000142424.65251.DB
   PubMed Web of Science ®Google Scholar
• Schurks M, Kurth T, Geissler I, et al. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology. 2006;66(12):1917–1919. doi: 10.1212/01.wnl.0000215852.35329.34
   PubMed Web of Science ®Google Scholar
• Rainero I, Gallone S, Rubino E, et al. Haplotype Analysis Confirms the Association between the HCRTR2 gene and cluster headache. Headache. 2008;48(7):1108–1114. doi: 10.1111/j.1526-4610.2008.01080.x
   PubMed Web of Science ®Google Scholar
• Baumber L, Sjostrand C, Leone M, et al. A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology. 2006;66(12):1888–1893. doi: 10.1212/01.wnl.0000219765.95038.d7
   PubMed Web of Science ®Google Scholar
• Schürks M, Kurth T, Geissler I, et al. The G1246A Polymorphism in the hypocretin receptor 2 gene is not associated with treatment response in cluster headache. Cephalalgia. 2007;27(4):363–367. doi: 10.1111/j.1468-2982.2007.01287.x
   PubMed Web of Science ®Google Scholar
• Burish MJ, Han C, Mawatari K, et al. The first-line cluster headache medication verapamil alters the circadian period and elicits sex-specific sleep changes in mice. Chronobiol Int. 2021;38(6):839–850. doi: 10.1080/07420528.2021.1892127
   PubMed Web of Science ®Google Scholar
• Cevoli S, Mochi M, Pierangeli G, et al. Investigation of the T3111C CLOCK gene polymorphism in cluster headache. J Neurol. 2008;255(2):299–300. doi: 10.1007/s00415-008-0719-8
   PubMed Web of Science ®Google Scholar
• Hirano A, Hsu P-K, Zhang L, et al. DEC2 modulates orexin expression and regulates sleep. Proc Natl Acad Sci, USA. 2018;115(13):3434. doi: 10.1073/pnas.1801693115
   PubMed Web of Science ®Google Scholar
• Barloese MCJ, Jennum PJ, Lund NT, et al. Sleep in cluster headache − beyond a temporal rapid eye movement relationship? Eur J Neurol. 2015;22(4):656–e40. doi: 10.1111/ene.12623
   PubMed Web of Science ®Google Scholar
• Marca GD, Vollono C, Rubino M, et al. Dysfunction of arousal systems in sleep-related migraine without aura. 2006;26(7): 857–64. doi: 10.1046/j.1468-2982.2002.00350.x-i1
   Google Scholar
• Zaremba S, Holle D, Wessendorf TE, et al. Cluster headache shows no association with rapid eye movement sleep. Cephalalgia. 2012;32(4):289–296. doi: 10.1177/0333102411436332
   PubMed Web of Science ®Google Scholar
• Feng H, Wen S-Y, Qiao Q-C, et al. Orexin signaling modulates synchronized excitation in the sublaterodorsal tegmental nucleus to stabilize REM sleep. Nat Commun. 2020;11(1):3661. doi: 10.1038/s41467-020-17401-3
   PubMed Web of Science ®Google Scholar
• Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(7):1987–1993. doi: 10.1093/brain/aww097
   PubMedGoogle Scholar
• Leso V, Gervetti P, Mauro S, et al. Shift work and migraine: a systematic review. J Occup Health. 2020;62(1):e12116. doi: 10.1002/1348-9585.12116
   PubMed Web of Science ®Google Scholar
• Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45(7):904–910. doi: 10.1111/j.1526-4610.2005.05159.x
   PubMed Web of Science ®Google Scholar
• Kumar H, Dhamija K, Duggal A, et al. Fatigue, chronic fatigue syndrome and migraine: intersecting the lines through a cross-sectional study in patients with episodic and chronic migraine. J Neurosci Rural Pract. 2023;14:424–431. doi: 10.25259/JNRP_63_2022
   PubMed Web of Science ®Google Scholar
• Brennan KC, Bates EA, Shapiro RE, et al. Casein Kinase Iδ Mutations in familial migraine and advanced sleep phase. Sci, trans med. 2013;5(183):183ra56. doi: 10.1126/scitranslmed.3005784
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Rainero I, Coppola F, et al. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and Medication-Overuse Headache: findings from cerebrospinal fluid. Cephalalgia. 2008;28(7):714–722. doi: 10.1111/j.1468-2982.2008.01566.x
   PubMed Web of Science ®Google Scholar
• Özaydin göksu E, Özaydin göksu S, Ünal A, et al. Orexin-A levels in episodic and chronic migraine: implications for hypothalamic involvement? J Neurol Sci. 2016;33:56–63.
   Google Scholar
• Pinessi L, Binello E, Martino PD, et al. The 1246 G/A polymorphism of the HCRTR2 gene is not associated with migraine. Cephalalgia. 2007;27(8):945–949. doi: 10.1111/j.1468-2982.2007.01347.x
   PubMed Web of Science ®Google Scholar
• Schürks M, Limmroth V, Geissler I, et al. Association between migraine and the G1246A Polymorphism in the hypocretin receptor 2 gene. Headache. 2007;47(8):1195–1199. doi: 10.1111/j.1526-4610.2007.00863.x
   PubMed Web of Science ®Google Scholar
• Rainero I, Rubino E, Gallone S, et al. Evidence for an association between migraine and the hypocretin receptor 1 gene. J Headache Pain. 2011;12(2):193–199. doi: 10.1007/s10194-011-0314-8
   PubMed Web of Science ®Google Scholar
• Kowalska M, Kapelusiak-Pielok M, Grzelak T, et al. The new *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 polymorphisms and hypocretin-1, serotonin concentrations in migraine patients. Front Mole Neurosci [Internet]. 2018;11 [cited 2023 May 18]. Available from: https://www.frontiersin.org/articles/10.3389/fnmol.2018.00191
   Google Scholar
• Watanabe S, Kuwaki T, Yanagisawa M, et al. Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport. 2005;16(1):5. doi: 10.1097/00001756-200501190-00002
   PubMed Web of Science ®Google Scholar
• Suzuki M, Beuckmann CT, Shikata K, et al. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res. 2005;1044(1):116–121. doi: 10.1016/j.brainres.2005.03.002
   PubMed Web of Science ®Google Scholar
• Johnson PL, Molosh A, Fitz SD, et al. Chapter 9 - Orexin, stress, and anxiety/panic states. In: Shekhar A, editor. Progress in brain research [internet]: Elsevier; 2012 cited 2023 May 18. p. 133–161. Available from: https://www.sciencedirect.com/science/article/pii/B9780444594891000094
   Google Scholar
• Peres MFP, Vieira DS, Masruha MR, et al. Orexin-A CSF levels correlate with anxiety but not excessive daytime sleepiness in chronic migraine. Headache Medicine. 2011;2:41–45. 2 10.48208/HeadacheMed.2011.9
   Google Scholar
• Zhu J-N, Guo C-L, Li H-Z, et al. Dorsomedial hypothalamic nucleus neurons integrate important peripheral feeding-related signals in rats. J Neurosci Res. 2007;85:3193–3204. 14 10.1002/jnr.21420
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB, Holland PR, et al. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology. 2007;68(21):1851–1861. doi: 10.1212/01.wnl.0000262045.11646.b1
   PubMed Web of Science ®Google Scholar
• Peterlin BL, Rapoport AM, Kurth T. Migraine and obesity: epidemiology, mechanisms, and implications. Headache. 2010;50(4):631–648. doi: 10.1111/j.1526-4610.2009.01554.x
   PubMed Web of Science ®Google Scholar
• Xue T, Wu X, Chen S, et al. The efficacy and safety of dual orexin receptor antagonists in primary insomnia: a systematic review and network meta-analysis. Sleep Med Rev. 2022;61:101573. doi: 10.1016/j.smrv.2021.101573
   PubMed Web of Science ®Google Scholar
• Weinhold SL, Seeck-Hirschner M, Nowak A, et al. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy. Behav Brain Res. 2014;262:8–13. doi: 10.1016/j.bbr.2013.12.045
   PubMed Web of Science ®Google Scholar
• Charles A. The migraine aura. Continuum. 2018;24(4):1009. doi: 10.1212/CON.0000000000000627
   PubMedGoogle Scholar
• Hoffmann J, Supronsinchai W, Akerman S, et al. Evidence for orexinergic mechanisms in migraine. Neurobiol Dis. 2015;74:137–143. doi: 10.1016/j.nbd.2014.10.022
   PubMed Web of Science ®Google Scholar
• Chabi A, Zhang Y, Jackson S, et al. Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis. Cephalalgia. 2015;35(5):379–388. doi: 10.1177/0333102414544979
   PubMed Web of Science ®Google Scholar
• Wimalawansa SJ Circadian variation of plasma calcitonin gene-related peptide in man. J Neuroendocrinology. 1991;3:319–322. 3 10.1111/j.1365-2826.1991.tb00281.x
   PubMed Web of Science ®Google Scholar
• van Oosterhout W, van Someren E, Schoonman G, et al. Chronotypes and circadian timing in migraine. Cephalalgia. 2018;38:617–625. doi: 10.1177/0333102417698953
   PubMed Web of Science ®Google Scholar
• Ong JC, Huang JS, Kuo TF, et al. Characteristics of Insomniacs with self-reported morning and evening chronotypes. J Clin Sleep Med. 2007;3(3):289–294. doi: 10.5664/jcsm.26801
   PubMed Web of Science ®Google Scholar
• Cardinali DP, Brown GM, Pandi-Perumal SR, et al. Chapter 24 - chronotherapy. In: Swaab D, Kreier F Lucassen P, editors. Handbook of clinical neurology [internet]: Elsevier; 2021 cited 2023 Feb 17. p. 357–370. Available from: https://www.sciencedirect.com/science/article/pii/B9780128199756000236
   Google Scholar
• Steiner TJ, Stovner LJ, Jensen R, et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. doi: 10.1186/s10194-020-01208-0
   PubMed Web of Science ®Google Scholar
• Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60(6):935–940. doi: 10.1212/01.WNL.0000052998.58526.A9
   PubMed Web of Science ®Google Scholar
• Iio K, Hashimoto K, Nagumo Y, et al. Design and synthesis of orexin 1 receptor-selective agonists. J Med Chem. 2023;66(8):5453–5464. doi: 10.1021/acs.jmedchem.2c01773
   PubMed Web of Science ®Google Scholar
• Ament M, Day K, Stauffer VL, et al. Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine. J Headache Pain. 2021;22(1):6. doi: 10.1186/s10194-021-01215-9
   PubMed Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WH Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system. J Pharm Sci. 2009;98:2501–2515. 7 10.1002/jps.21604
   PubMed Web of Science ®Google Scholar